# Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)

> **NCT03249285** · PHASE3 · UNKNOWN · sponsor: **Ospedale San Raffaele** · enrollment: 300 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Peri
- **DRUG:** HCTZ

## Key facts

- **NCT ID:** NCT03249285
- **Lead sponsor:** Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2018-03
- **Final completion:** 2018-11
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249285, "Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03249285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*